Nettacin (Netilmicin Sulfate)

Nettacin, an aminoglycoside antibiotic, is used to manage bacterial infections of the eye and is applied directly to the affected tissue.

• Bacterial conjunctivitis: reduces bacterial load, shortens duration of redness, tearing and purulent discharge, and promotes faster symptom relief.
• Keratitis: treats corneal bacterial infection, helps prevent ulcer formation, supports corneal healing, and preserves visual acuity when used promptly.
• Blepharitis: controls bacterial overgrowth at the eyelid margin, diminishes inflammation, crusting and irritation, and improves eyelid hygiene.

• Netilmicin binds to the bacterial 30S ribosomal subunit, causing misreading of mRNA and inhibition of protein synthesis. This bactericidal action interferes with essential cellular functions, leading to rapid bacterial cell death, particularly against Gram‑negative and some Gram‑positive ocular pathogens. The drug penetrates the corneal epithelium and conjunctival tissues, achieving therapeutic concentrations at the site of infection while exhibiting minimal systemic absorption.

Netilmicin ophthalmic solution may cause local ocular reactions and, rarely, systemic effects.

Common Side Effects

• Burning or stinging sensation upon instillation.
• Transient eye redness.
• Mild itching or irritation.
• Temporary blurred vision.

Serious or Rare Side Effects

• Allergic hypersensitivity reactions such as eyelid edema, rash or conjunctival swelling.
• Corneal ulceration or severe keratitis if used improperly.

Before prescribing Nettacin, clinicians should consider several safety and handling precautions.

• Indication verification: confirm bacterial etiology and appropriate ocular infection before use.
• Patient age: use only in patients for whom the prescriber determines benefit outweighs risk; pediatric use requires careful assessment.
• Contact lens wear: advise patients to remove lenses before instillation and wait before reinserting.
• Concomitant ocular medications: avoid mixing with other eye drops unless directed, to prevent dilution or interaction.
• Systemic absorption: monitor patients with renal impairment, as aminoglycosides can accumulate systemically.
• Store at room temperature: keep below 25°C, protect from light and moisture, and retain in original container.

Netilmicin may interact with other agents that affect renal function or ocular surface integrity.

Major Interactions (Avoid)

• Nephrotoxic drugs (e.g., vancomycin, amphotericin B): concurrent use can increase risk of systemic aminoglycoside toxicity.
• Loop diuretics (e.g., furosemide): may potentiate renal accumulation if systemic absorption occurs.

Moderate Interactions (Monitor Closely)

• Other ophthalmic antibiotics: combined use may alter local flora and increase resistance risk.
• Topical corticosteroids: may mask signs of infection, requiring close monitoring.
• Anticholinergic eye drops: can reduce tear production, potentially affecting drug distribution.